Cholesteryl ester (CE)-loaded macrophages (foam cells) are a prominent feature of atherosclerotic plaques. Previous studies have shown that human monocytes or resident mouse peritoneal macrophages accumulate CE in response to low density lipoprotein (LDL) only when the LDL has been appropriately chemically modified. By contrast, we report here that J774 macrophages accumulate large amounts of CE when incubated with unmodified LDL. The CE is stored in oil red 0-positive droplets, which have the typical appearance of foam cell inclusions by electron microscopy. (3), and LDL has been implicated as the major atherogenic lipoprotein (1); thus, the possibility exists that, under certain circumstances not yet elucidated, LDL could lead to CE accumulation. Investigations into the mechanism of CE accumulation in macrophages, which are thought to be the major source of atheromatous foam cells (3), have primarily utilized two models-mouse peritoneal macrophages and human monocytes (4). These studies have revealed that CE accumulation can be induced by LDL only when the LDL is modified by negative charges [e.g., acetyl-LDL and malondialdehyde-LDL) via the "scavenger receptor" (4)]. Although the studies with modified LDL suggest that LDL may have to be altered in order to realize its atherogenic potential, it is not known whether peritoneal macrophages or blood-borne monocytes are appropriate models for foam cell formation or whether sufficient quantities of the modified lipoproteins exist in vivo to result in significant macrophage CE accumulation. We report here that a macrophage cell line, the mouse J774 cell, does accumulate large amounts of CE when incubated with native LDL, providing an example of unmodified LDL inducing foam cell formation.
reductase activity in J774 cells are relatively resistant to down-regulation by LDL or 25-hydroxycholesterol, leading to receptor-mediated CE storage. In addition, J774 cells appear to accumulate CE from LDL internalized by nonspecific means. Thus, macrophage-like cells can accumulate CE in response to unmodified LDL by both nonspecific and receptormediated processes.
Low density lipoprotein (LDL) uptake by most cultured cells does not lead to substantial cellular cholesterol accumulation (1, 2). However, a prominent feature of atherosclerotic lesions are cholesteryl ester (CE)-loaded foam cells (3) , and LDL has been implicated as the major atherogenic lipoprotein (1); thus, the possibility exists that, under certain circumstances not yet elucidated, LDL could lead to CE accumulation. Investigations into the mechanism of CE accumulation in macrophages, which are thought to be the major source of atheromatous foam cells (3) , have primarily utilized two models-mouse peritoneal macrophages and human monocytes (4) . These studies have revealed that CE accumulation can be induced by LDL only when the LDL is modified by negative charges [e.g., acetyl-LDL and malondialdehyde-LDL) via the "scavenger receptor" (4) ]. Although the studies with modified LDL suggest that LDL may have to be altered in order to realize its atherogenic potential, it is not known whether peritoneal macrophages or blood-borne monocytes are appropriate models for foam cell formation or whether sufficient quantities of the modified lipoproteins exist in vivo to result in significant macrophage CE accumulation. We report here that a macrophage cell line, the mouse J774 cell, does accumulate large amounts of CE when incubated with native LDL, providing an example of unmodified LDL inducing foam cell formation.
MATERIALS AND METHODS -
Cells. Monolayer cultures of the J774 macrophage-like cell line (5) , obtained from Jay Unkeless (The Rockefeller University), were maintained in Dulbecco's modified Eagle's medium (DME medium) containing 10%o heat-inactivated (560C for 30 min) fetal bovine serum (medium A). The cells were demonstrated to have the following macrophage-like characteristics; adherence to plastic, phagocytosis of latex particles and antibody-coated sheep erythrocytes, positive staining for peroxidase and nonspecific esterase, and positive enzyme assays for B3-glucuronidase and acid phosphatase. Several tests of the culture for mycoplasma contamination were negative. Normal newborn human fibroblasts (frozen in the sixth passage), kindly provided by Joseph Cornicelli, (Columbia University) were grown in DME medium containing 10% fetal bovine serum. Mouse peritoneal macrophages and P388D1 cells (5), obtained from John Wunderlich (National Institutes of Health), were grown in medium A. HL 60 cells (5), obtained from T. R. Breitman (National Institutes of Health), were maintained in RPM1 1640 medium supplemented with 10% heat-inactivated fetal bovine serum; the cells were induced to differentiate into mature macrophage-like cells by treatment with 16 nM phorbol 12-myristate 13-acetate.
Lipoproteins. LDL (density, 1.020-1.063 g/ml), very low density lipoprotein (VLDL; density < 1.006 g/ml), and high density lipoproteins 3 and 2 [HDL3 (density, 1.125-1.21 g/ml) and HDL2 (density, 1.063-1.125 g/ml)] from fresh human plasma and lipoprotein-deficient serum (LPDS; density > 1.215 g/ml) from fetal bovine serum were isolated by preparative ultracentrifugation. 1251I-labeled LDL (125I-LDL) was prepared by the iodine monochloride method as described (6). Acetyl-LDL was prepared by reaction with acetic anhydride as described by Basu and co-workers (7). Cellular Lipid Mass Assays. Cell monolayers were incubated at 370C with medium A or DME medium containing 5% LPDS and 2% bovine serum albumin (medium B) plus the indicated amount of LDL. The cells then were washed and collected as described (8) ; after an aliquot was removed for protein determination, the cells were lipid-extracted by the method of Folch et al. (9) . The average protein contents per dish were 1.0 mg for J774 cells and 0.4 mg for mouse peritoneal macrophages.
Abbreviations: CE, cholesteryl ester; LDL, low density lipoprotein; VLDL, very low density lipoprotein; HDL, high density lipoprotein; DME medium, Dulbecco's modified Eagle's medium; LPDS, lipoprotein-deficient serum; HMG-CoA reductase, 3-hydroxy-3-methylglutaryl-coenzyme A reductase; apo, apolipoprotein; ACAT, acyl-CoA:cholesterol acyltransferase.
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Cell-Association and Degradation Assays. Cell monolayers were incubated at 370C with 1 ml of medium B containing 125I-LDL (specific activity, 50 cpm per ng) alone or in combination with unlabeled lipoproteins. Cell association and degradation of 1251-LDL was assayed as described (6) .
The average protein contents per dish were 1.0 mg for J774 cells and 0.25 mg for fibroblasts. Specific cell association was calculated by subtracting the value for nonspecific cell association (125I-LDL plus excess unlabeled LDL) from the value for total cell association (125I-LDL alone).
Cell Binding Assay. Direct 40C binding assays with dextran sulfate to release the bound 125I-LDL (80% release) were performed as described by Goldstein et al. (6) . 3-Hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) Reductase Assay. Cells were assayed for HMG-CoA reductase activity as described (6) .
Analytical Procedures. Macrophage monolayers were prepared for electron microscopy as described (10) . Rates for pinocytosis, expressed as nl of bulk-phase fluid taken up by J774 cells, were determined from the uptake of [3H]sucrose in the presence of 300 /ig/ml of LDL as described elsewhere (11). Protein content was determined by the method of Lowry et al. (12) with bovine serum albumin as the standard. Cellular lipid extracts were analyzed for free and total cholesterol content by GLC (13) and for phosphate content by the method of Bartlett (14) . Methyl esters of fatty acids of cholesterol esters and triglycerides (15) were analyzed by GLC.
RESULTS
Incubation of J774 macrophages with LDL resulted in pronounced accumulation of CE (Fig. 1) . By contrast, our experiments showed that incubation of LDL with resident mouse peritoneal macrophages did not result in significant CE accumulation (Fig. 1) , confirming previously reported data (4) . Exposure of J774 cells to a high LDL concentration for longer periods than shown in Fig. 1 Fig. 2 . Fig. 2B shows the characteristic electron microscopic appearance of intracellular neutral lipid droplets (the control cell without droplets is shown in Fig. 2A (Fig. 3A) and degradation (Fig. 3B) were determined. Both specific cellular association and specific degradation demonstrated saturability, whereas nonspecific cellular association and degradation increased linearly and reached values equal to those of the specific processes at an 125I-LDL concentration of 300 ,g/ml. Time course studies revealed that, whereas specific 125I-LDL cellular association reached a maximum value at 6 hr and then remained constant ( Fig. 3C) , specific 125I-LDL degradation progressed continuously for at least 8 hr (Fig. 3D ). Both nonspecific cellular association and nonspecific degradation progressed linearly throughout the time period (Fig. 3 C and D) .
Studies performed at 40C to assess direct binding of 125I-LDL to J774 macrophages also demonstrated highaffinity, saturable, specific interaction of 125I-LDL with the cells (Fig. 4) . When cells that had bound 125I-LDL at 40C were subsequently incubated at 370C for 3 hr in the presence of excess unlabeled LDL, 83% of the 125I-LDL was degraded; thus, the binding sites assayed at 40C were functionally related to subsequent 125I-LDL degradation. Scatchard analysis of the specific component of binding ( containing lipoprotein, displaced 125I-LDL almost as well as LDL (Fig. 5) ; HDL2, which contains some apo E (17),
showed moderate displacement of 125I-LDL. HDL3, which contains no apo B or apo E, and acetyl-LDL, whose apo B is modified and no longer recognized by the apo B/E receptor (7), displayed very poor displacement of 12 I-LDL.
Further studies revealed that specific 1251I-LDL degradation was inhibited 40% by 25 ,um chloroquine, 75% by 5 ug of Pronase per ml, and 96% by 5 mM EDTA. These experiments show that J774 cells possess an LDL receptor with many characteristics of the apo B/E receptor characterized previously in other cells (1, 17) .
Experiments were next undertaken to determine the mechanism of CE accumulation. Since previous studies have shown that CE accumulates in macrophages as a result of scavenger receptor uptake of modified LDL (6), we considered the possibility that CE accumulated in J774 cells because LDL was modified in the medium of J774 cells, allowing recognition by the J774 scavenger receptor. However, cell association and degradation studies at 370C showed that acetyl LDL was a very poor competitive inhibitor of 125I-LDL, similar to the results of the 40C binding studies (above). Also, exposure of mouse peritoneal macrophages to either LDL that had been exposed to J774 cells or fresh LDL in J774 cell-conditioned medium did not result in CE accumulation in these cells. Thus, LDL is not modified in the medium to a form that is internalized by the scavenger receptor.
We next considered the possibility that J774 cells accumulate large amounts of CE when incubated with LDL because the cells lack the ability to adequately downregulate their LDL receptor and HMG-CoA reductase. In these experiments we compared the properties of the LDL receptor of J774 cells with those of the classical LDL receptor in human fibroblast. Normal human fibroblasts and J774 cells were preincubated with either increasing concentrations of LDL or 25-hydroxycholesterol and then were assayed for 1251-LDL degradation and HMG-CoA reductase activity (Fig. 6) . The control values for both degradation and enzyme activity were similar in both cell lines (see the legend to Fig. 6 ). However, in comparison with fibroblasts, J774 cells showed much less suppression of both specific 1251. LDL degradation and HMG-CoA reductase activity, following either LDL or 25-hydroxycholesterol preincubation. Growth curve analysis of the cells used in this study indicated that both the J774 cells and the fibroblasts were growing at similar rates (late logarithmic growth phase); thus, the diminished down-regulatory response does not simply reflect a property of rapidly growing cells.
Note in Fig. 6 that preincubation of J774 cells with a high concentration of LDL (300,ug/ml) caused a 70% decrease in 125I-LDL degradation. Additional studies of 4°C binding revealed that preincubation of J774 cells with 100 ,tg of acetyl-LDL per ml for 24 hr, which led to the accumulation of 120 ,ug of CE per mg of cell protein, caused an 83% decrease in 125I-LDL binding. Similarly, incubation of J774 cells with LDL or acetyl-LDL for a longer time period than that utilized in Fig. 6 (30 hr vs. 7 hr) led to a further reduction in HMG-CoA reductase activity (maximal inhibition of reductase activity observed was 88% after a 30-hr incubation in the presence of 600,ug of LDL or 100 ,ug of acetyl-LDL per ml).
Another property that appeared to be important was the ability of J774 macrophages to store CE from LDL that had entered the cell by nonspecific means. This property was suggested by the observation that the shape of the concentration curve for total cholesterol or CE mass accumulation (Fig. 1 Upper) was parallel to that of the concentration curves for total 125I-LDL cellular association and total degradation (Fig. 3 A and B, respectively) , suggesting that both specific and nonspecific uptake of LDL contribute to the accumulation of cholesterol in J774 cells. By using the 125I-LDL cellular association and degradation data in Fig. 3 A and B (data points for LDL at 300 ,g/ml), it can be estimated that -85% of the total cholesterol accumulated by the cell after LDL exposure could be accounted for by 125I-LDL cellular association plus degradation, and, of this amount, approximately equal proportions were obtained by specific and nonspecific means. Furthermore, by measuring [3H]sucrose uptake as an estimation of fluid-phase pinocytosis, we calculated that -37% of the nonspecifically obtained LDL total cholesterol was acquired through fluid pinocytosis, while the rest was acquired through either nonspecific absorptive endocytosis or through some other nonspecific mechanism. Thus, unlike fibroblasts (2), J774 macrophages have the ability to obtain large amounts of LDL total cholesterol (mostly CE) by nonspecific mechanisms.
Another possible mechanism of CE accumulation that we considered was that J774 macrophages might have a defect in the hydrolysis of stored CE or in the excretion of free cholesterol. However, this does not appear to be the case since CE-loaded J774 macrophages, when incubated with apo HDL-phospholipid synthetic discs, became significantly depleted of CE (65% reduction after 24-hr incubation with discs) because of excretion of cholesterol into the medium.
Results were similar to CE-loaded mouse peritoneal macrophages exposed to synthetic discs (62% reduction in CE content per 24 hr).
Cell Biology: Tabas et al.
Proc. Natl. Acad. Sci. USA 82 (1985) DISCUSSION We have demonstrated that J774 macrophages can accumulate large amounts of CE when incubated with unmodified LDL. The LDL is internalized both by a specific apo B/E-like receptor and by nonspecific mechanisms; after internalization, the LDL-CE is hydrolyzed in the lysosomes, reesterified by ACAT, and stored in CE droplets inside the cell. The LDL receptor and HMG-CoA reductase are relatively resistant to down-regulation by LDL, a factor that contributes to the accumulation of CE in the cells. Also, nonspecific mechanisms account for a significant portion of CE accumulation at high LDL concentrations.
Other investigators have demonstrated 'l25-labeled native LDL cell association with and degradation by macrophages or monocytes after incubation in LPDS (18, 19) . However, this LDL receptor activity does not lead to CE accumulation (18, 19) , which may be at least partially related to the fact that human monocyte macrophages, in contrast to J774 macrophages, almost completely suppress 125I-LDL degradation and cholesterol biosynthesis when preincubated with LDL (18) . The hypothesis that resistant down-regulation contributes to the ability of J774 cells to accumulate CE is supported by reports of analogous behavior in other cell types. Acetyl-LDL, which does not lead to down-regulation of its own ("scavenger") receptor, causes CE accumulation in mouse peritoneal macrophages and monocytes (4) . Similarly, Chang and Chang (20) have isolated two Chinese hamster ovary (CHO) cell mutants whose HMG-CoA reductase demonstrates a diminished down-regulatory response to 25-hydroxycholesterol and fetal calf serum; these mutant cells, in contrast to the wild-type cells, accumulate significant amounts of CE when incubated with fetal calf serum (20) . In J774 cells, the fact that both the LDL receptor and HMG-CoA reductase demonstrate relatively resistant downregulation may indicate that there is a defect in a common regulatory mechanism. However, it is also possible that the property of resistant down-regulation resides in the receptor and enzyme molecules themselves.
We have shown that at high 1251I-LDL concentrations, a large proportion of the lipoprotein enters J774 cells by nonspecific mechanisms (Fig. 3) . This nonspecifically internalized LDL probably plays an important role in the accumulation of CE by these cells since the LDL doseresponse curve for CE mass accumulation (Fig. 1 Upper) more closely resembles those of total 125I-LDL cell association and degradation rather than those of the respective specific processes (Fig. 3 A and B) . In addition, nonspecifically internalized LDL probably also contributes to a portion of the down-regulation that does occur in these cells, since high concentrations of LDL lead to a further diminution of LDL receptor and HMG-CoA reductase activities. Fibroblasts also internalize large amounts of LDL through nonspecific means at high LDL concentration (1) but do not accumulate large amounts of CE (2) and do not downregulate their LDL receptors or HMG-CoA reductase (1) by this means. Thus, the metabolism of nonspecifically internalized LDL in J774 cells may be fundamentally different from that in fibroblasts.
The data we have presented in this report were obtained with the J774 cell line, which is derived from a tumor. In addition, J774 macrophages, like other macrophages, have both the scavenger-receptor (above) and the 1-VLDL receptor (8) and secrete lipoprotein lipase (21 (22) . In addition, Ho et al. (23) showed that freshly isolated acute leukemia cells contained almost no CE, and the LDL receptor on these cells was downregulated normally by LDL and 25-hydroxycholesterol. Thus, the J774 cell-line represents a useful macrophage model, and its unique properties in interacting with native LDL are not general tumor cell properties. The J774 cell, by virtue of its diminished down-regulatory response to LDL, may be a potentially valuable tool to help understand the mechanism of LDL-induced receptor and reductase downregulation. Finally, the J774 macrophage, which is the first macrophage shown to accumulate CE in the presence of unmodified LDL, may serve as a model to help explore the possibility that foam cell formation involves the interaction of native LDL with metabolically altered cells.
